Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
September 16, 2025Indonesian Journal of Tropical and Infectious DiseaseOpen Access

Update on The Current Management of Drug Resistant Tuberculosis (DR-TB)

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRohani Lasmaria SimbolonESElvando Tunggul Mauliate SimatupangIYIndra Yovi

Discussion

Loading...

Member takes

Overview

Current updates show decreased treatment success in DR-TB cases, suggesting new management strategies are needed.

Key Points

  • Treatment success rates for DR-TB in Indonesia range from 45-50%, highlighting a critical public health challenge.
  • The introduction of the Xpert MTB/XDR test aids in accurate diagnostics, crucial for effective DR-TB management.
  • The recommended BPaLM/BPaL regimen aims to minimize treatment dropout and enhance patient compliance.
  • Recent WHO guidelines emphasize the shift to shorter-duration regimens for better patient outcomes in DR-TB cases.

Cite This Study

Simbolon et al. (2025) studied this question.

synapsesocial.com/papers/68d42718713b0b5dfea6d570https://doi.org/10.20473/ijtid.v13i2.59075
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Emerging Therapeutic Approaches to Drug-Resistant Tuberculosis: Compressive Review2025
  2. 2Anti-TB Drugs for Drug-Sensitive and Drug-Resistant Mycobacterium tuberculosis: A Review2025 · 5 citations
  3. 3Diagnosis and Treatment of Multidrug/Rifampicin-Resistant Tuberculosis2025
  4. 4Evaluating Treatment Outcomes in Special Populations with Multidrug- and Extensively Drug-Resistant Tuberculosis: A Comparative Cohort Study2025
  5. 5Pakistan’s path forward in DR-TB management: insights from global implementation of BPaL/BPaLM regimen2025